Filtered By:
Condition: Bleeding
Education: Conferences
Management: Mergers and Aquisitions
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
How Did Medtronic ’s HVAD Perform in LATERAL Trial?
Medtronicâs HeartWare HVAD pump system could get a significant boost after performing well in the LATERAL clinical trial.
The Dublin-based company presented results from the study at the American Society for Artificial Internal Organs 65th Annual Conference, that showed patients who received the system had 95% freedom from disabling stroke at two years.
The medtech giant now plans to launch a global registry to collect additional clinical evidence to further characterize survival, adverse events, and economic benefits of the HVAD System.
The HVAD Pump is a left ventricle assist device (LVAD) approved in t...
Source: MDDI - July 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news